Ren Dabin, Almudevar Anthony L, Pichichero Michael E
a Rochester General Hospital Research Institute ; Rochester , NY USA.
Hum Vaccin Immunother. 2015;11(2):489-97. doi: 10.4161/21645515.2014.990861.
Conserved Streptococcus pneumoniae (Spn) proteins are currently under investigation as vaccine candidates. We recently identified a subset of children prone to frequent acute otitis media (AOM) that we refer to as stringently-defined otitis prone (sOP). We investigated the synchrony of serum antibody responses against 5 Spn protein vaccine antigens, PhtD, LytB, PcpA, PhtE, and PlyD1 resulting from nasopharyngeal colonization and AOM in sOP children (49 observations) and non-otitis prone (NOP) children (771 observations). Changes in serum IgG and IgM were quantitated with ELISA. IgG antibody concentrations against PhtD, PcpA, and PlyD1 rose in synchrony in sOP and NOP children; that is, the proteins appeared equally and highly immunogenic in children at age 6 to 15 months and then leveled off in their rise at 15 to 25 months. In contrast, rises in concentrations to PhtE and LytB were significantly slower and had not peaked in children even at 25 months of age, consistent with lower immunogenicity. Serum IgM responses against PhtD and PlyD1 were in synchrony in children at age 6-25 months old. PcpA did not induce a significant increase of serum IgM response in children, suggesting that primary responses to PcpA occurred prior to children attaining age 6 months old. PhtD, PcpA, and Ply elicit a synchronous natural acquisition of serum antibody in young children suggesting that a trivalent Spn protein vaccine combining PhtD, PcpA, and PlyD1 would be less likely to display antigen competition when administered as a combination vaccine in young children.
保守的肺炎链球菌(Spn)蛋白目前正作为疫苗候选物进行研究。我们最近发现了一部分易患频繁急性中耳炎(AOM)的儿童,我们将其称为严格定义的中耳炎易感(sOP)儿童。我们研究了sOP儿童(49例观察对象)和非中耳炎易感(NOP)儿童(771例观察对象)因鼻咽部定植和AOM而产生的针对5种Spn蛋白疫苗抗原(PhtD、LytB、PcpA、PhtE和PlyD1)的血清抗体反应的同步性。用酶联免疫吸附测定法(ELISA)定量血清IgG和IgM的变化。sOP和NOP儿童中针对PhtD、PcpA和PlyD1的IgG抗体浓度同步上升;也就是说,这些蛋白在6至15个月大的儿童中具有同等且高度的免疫原性,然后在15至25个月时其上升趋于平稳。相比之下,针对PhtE和LytB的浓度上升明显较慢,甚至在25个月大的儿童中也未达到峰值,这与较低的免疫原性一致。6至25个月大的儿童中针对PhtD和PlyD1的血清IgM反应同步。PcpA未在儿童中诱导血清IgM反应显著增加,这表明对PcpA的初次反应发生在儿童6个月大之前。PhtD、PcpA和Ply在幼儿中引发血清抗体的同步自然获得,这表明将PhtD、PcpA和PlyD1组合的三价Spn蛋白疫苗作为联合疫苗在幼儿中给药时不太可能出现抗原竞争。